Literature DB >> 581127

Ocular hypertension. A 15-year follow-up.

P N Sørensen, N V Nielsen, K Nørskov.   

Abstract

A group of 55 subjects with ocular hypertension were followed-up after 15 years. They were detected at a glaucoma screening on the island of Falster between 2031 volunteer blood donors, and they had an applanation pressure of greater than or equal to 20 mmHg in one or both eyes. All the subjects were traced. Nine have died, all from general causes, and one of the deceased subjects was treated for simple glaucoma. Of the remaining 46 living subjects, 3 developed glaucomatous visual field defects despite treatment. In another 4 subjects anti-glaucoma treatment was felt to be indicated. Of the non-treated 39 living subjects, 20 had a decreased applanation pressure, well below 20 mmHg, and 19 had an unaltered applanation pressure. We found that neither the common blood groups nor a water provocative test performed in 1962 were of any help in predicting glaucomatous visual field defects. Central corneal thickness measurements performed in 1977 could not allocate the subjects to the groups simple glaucoma, applanation pressure greater than 20 mmHg or less than or equal to 20 mmHg.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581127     DOI: 10.1111/j.1755-3768.1978.tb05689.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  7 in total

1.  Combined exfoliation and pigment dispersion: an overlap syndrome.

Authors:  R Mudumbai; J M Liebmann; R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  The pattern electroretinogram in glaucoma and ocular hypertension.

Authors:  E O'Donaghue; G B Arden; F O'Sullivan; F Falcão-Reis; B Moriarty; R A Hitchings; W Spilleers; C Hogg; G Weinstein
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

3.  Does medical treatment of mild intraocular hypertension prevent glaucoma?

Authors:  I Aguinaga Ontoso; F Guillen Grima; E Aguinaga Ontoso; L R Fernandez Fernandez
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

4.  Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.

Authors:  M A Kass
Journal:  Trans Am Ophthalmol Soc       Date:  1989

5.  Ocular hypertension and posture.

Authors:  T J Leonard; M G Kerr Muir; G R Kirkby; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1983-06       Impact factor: 4.638

6.  The prevalence of glaucoma.

Authors:  B Bengtsson
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

7.  The optic disc in glaucoma. IV: Optic disc evaluation in the ocular hypertensive patient.

Authors:  R A Hitchings; C A Wheeler
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.